Selected research
Industry Research
AI-Based Infection Control System Industry Research Report 2026
Market perspective
The global AI-Based Infection Control System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI-Based Infection Control System market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI-Based Infection Control System market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI-Based Infection Control System market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI-Based Infection Control System include IBM Watson Health, Siemens Healthineers, Philips Healthcare, Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions, SAS Institute Inc., GE Healthcare and McKesson Corporation, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI-Based Infection Control System market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI-Based Infection Control System.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI-Based Infection Control System Market by Company
IBM Watson Health
Siemens Healthineers
Philips Healthcare
Cerner Corporation
Epic Systems Corporation
Allscripts Healthcare Solutions
SAS Institute Inc.
GE Healthcare
McKesson Corporation
Optum
Premier Inc.
RL Solutions
BioVigil Healthcare Systems
SwipeSense
GOJO Industries
AI-Based Infection Control System Segment by Type
EMR/EHR-Based Analytics
Real-Time Vitals & Sensor Data Analytics
IoT Device Sensor Integration
AI-Based Infection Control System Segment by Application
Hospitals & ICUs
Surgical Rooms & Isolation Wards
Long-Term Care Facilities
Laboratories & Diagnostic Centers
Public Health Infection Monitoring
AI-Based Infection Control System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-Based Infection Control System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI-Based Infection Control System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-Based Infection Control System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI-Based Infection Control System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- EMR/EHR-Based Analytics
- Real-Time Vitals & Sensor Data Analytics
- IoT Device Sensor Integration
Applications
- Hospitals & ICUs
- Surgical Rooms & Isolation Wards
- Long-Term Care Facilities
- Laboratories & Diagnostic Centers
- Public Health Infection Monitoring
Companies covered
- IBM Watson Health
- Siemens Healthineers
- Philips Healthcare
- Cerner Corporation
- Epic Systems Corporation
- Allscripts Healthcare Solutions
- SAS Institute Inc.
- GE Healthcare
- McKesson Corporation
- Optum
- Premier Inc.
- RL Solutions
- BioVigil Healthcare Systems
- SwipeSense
- GOJO Industries
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI-Based Infection Control System by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 EMR/EHR-Based Analytics
- 2.2.3 Real-Time Vitals & Sensor Data Analytics
- 2.2.4 IoT Device Sensor Integration
- 2.3 AI-Based Infection Control System by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals & ICUs
- 2.3.3 Surgical Rooms & Isolation Wards
- 2.3.4 Long-Term Care Facilities
- 2.3.5 Laboratories & Diagnostic Centers
- 2.3.6 Public Health Infection Monitoring
- 2.4 Assumptions and Limitations
3 AI-Based Infection Control System Breakdown Data by Type
- 3.1 Global AI-Based Infection Control System Historic Market Size by Type (2021-2026)
- 3.2 Global AI-Based Infection Control System Forecasted Market Size by Type (2027-2032)
4 AI-Based Infection Control System Breakdown Data by Application
- 4.1 Global AI-Based Infection Control System Historic Market Size by Application (2021-2026)
- 4.2 Global AI-Based Infection Control System Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI-Based Infection Control System Market Perspective (2021-2032)
- 5.2 Global AI-Based Infection Control System Growth Trends by Region
- 5.2.1 Global AI-Based Infection Control System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI-Based Infection Control System Historic Market Size by Region (2021-2026)
- 5.2.3 AI-Based Infection Control System Forecasted Market Size by Region (2027-2032)
- 5.3 AI-Based Infection Control System Market Dynamics
- 5.3.1 AI-Based Infection Control System Industry Trends
- 5.3.2 AI-Based Infection Control System Market Drivers
- 5.3.3 AI-Based Infection Control System Market Challenges
- 5.3.4 AI-Based Infection Control System Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI-Based Infection Control System Players by Revenue
- 6.1.1 Global Top AI-Based Infection Control System Players by Revenue (2021-2026)
- 6.1.2 Global AI-Based Infection Control System Revenue Market Share by Players (2021-2026)
- 6.2 Global AI-Based Infection Control System Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI-Based Infection Control System Head Office and Area Served
- 6.4 Global AI-Based Infection Control System Players, Product Type & Application
- 6.5 Global AI-Based Infection Control System Manufacturers Established Date
- 6.6 Global AI-Based Infection Control System Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI-Based Infection Control System Market Size (2021-2032)
- 7.2 North America AI-Based Infection Control System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI-Based Infection Control System Market Size by Country (2021-2026)
- 7.4 North America AI-Based Infection Control System Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI-Based Infection Control System Market Size (2021-2032)
- 8.2 Europe AI-Based Infection Control System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI-Based Infection Control System Market Size by Country (2021-2026)
- 8.4 Europe AI-Based Infection Control System Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI-Based Infection Control System Market Size (2021-2032)
- 9.2 Asia-Pacific AI-Based Infection Control System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI-Based Infection Control System Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI-Based Infection Control System Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI-Based Infection Control System Market Size (2021-2032)
- 10.2 South America AI-Based Infection Control System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI-Based Infection Control System Market Size by Country (2021-2026)
- 10.4 South America AI-Based Infection Control System Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI-Based Infection Control System Market Size (2021-2032)
- 11.2 Middle East & Africa AI-Based Infection Control System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI-Based Infection Control System Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI-Based Infection Control System Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 IBM Watson Health
- 12.1.1 IBM Watson Health Company Information
- 12.1.2 IBM Watson Health Business Overview
- 12.1.3 IBM Watson Health Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.1.4 IBM Watson Health AI-Based Infection Control System Product Portfolio
- 12.1.5 IBM Watson Health Recent Developments
- 12.2 Siemens Healthineers
- 12.2.1 Siemens Healthineers Company Information
- 12.2.2 Siemens Healthineers Business Overview
- 12.2.3 Siemens Healthineers Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.2.4 Siemens Healthineers AI-Based Infection Control System Product Portfolio
- 12.2.5 Siemens Healthineers Recent Developments
- 12.3 Philips Healthcare
- 12.3.1 Philips Healthcare Company Information
- 12.3.2 Philips Healthcare Business Overview
- 12.3.3 Philips Healthcare Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.3.4 Philips Healthcare AI-Based Infection Control System Product Portfolio
- 12.3.5 Philips Healthcare Recent Developments
- 12.4 Cerner Corporation
- 12.4.1 Cerner Corporation Company Information
- 12.4.2 Cerner Corporation Business Overview
- 12.4.3 Cerner Corporation Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.4.4 Cerner Corporation AI-Based Infection Control System Product Portfolio
- 12.4.5 Cerner Corporation Recent Developments
- 12.5 Epic Systems Corporation
- 12.5.1 Epic Systems Corporation Company Information
- 12.5.2 Epic Systems Corporation Business Overview
- 12.5.3 Epic Systems Corporation Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.5.4 Epic Systems Corporation AI-Based Infection Control System Product Portfolio
- 12.5.5 Epic Systems Corporation Recent Developments
- 12.6 Allscripts Healthcare Solutions
- 12.6.1 Allscripts Healthcare Solutions Company Information
- 12.6.2 Allscripts Healthcare Solutions Business Overview
- 12.6.3 Allscripts Healthcare Solutions Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.6.4 Allscripts Healthcare Solutions AI-Based Infection Control System Product Portfolio
- 12.6.5 Allscripts Healthcare Solutions Recent Developments
- 12.7 SAS Institute Inc.
- 12.7.1 SAS Institute Inc. Company Information
- 12.7.2 SAS Institute Inc. Business Overview
- 12.7.3 SAS Institute Inc. Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.7.4 SAS Institute Inc. AI-Based Infection Control System Product Portfolio
- 12.7.5 SAS Institute Inc. Recent Developments
- 12.8 GE Healthcare
- 12.8.1 GE Healthcare Company Information
- 12.8.2 GE Healthcare Business Overview
- 12.8.3 GE Healthcare Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.8.4 GE Healthcare AI-Based Infection Control System Product Portfolio
- 12.8.5 GE Healthcare Recent Developments
- 12.9 McKesson Corporation
- 12.9.1 McKesson Corporation Company Information
- 12.9.2 McKesson Corporation Business Overview
- 12.9.3 McKesson Corporation Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.9.4 McKesson Corporation AI-Based Infection Control System Product Portfolio
- 12.9.5 McKesson Corporation Recent Developments
- 12.10 Optum
- 12.10.1 Optum Company Information
- 12.10.2 Optum Business Overview
- 12.10.3 Optum Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.10.4 Optum AI-Based Infection Control System Product Portfolio
- 12.10.5 Optum Recent Developments
- 12.11 Premier Inc.
- 12.11.1 Premier Inc. Company Information
- 12.11.2 Premier Inc. Business Overview
- 12.11.3 Premier Inc. Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.11.4 Premier Inc. AI-Based Infection Control System Product Portfolio
- 12.11.5 Premier Inc. Recent Developments
- 12.12 RL Solutions
- 12.12.1 RL Solutions Company Information
- 12.12.2 RL Solutions Business Overview
- 12.12.3 RL Solutions Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.12.4 RL Solutions AI-Based Infection Control System Product Portfolio
- 12.12.5 RL Solutions Recent Developments
- 12.13 BioVigil Healthcare Systems
- 12.13.1 BioVigil Healthcare Systems Company Information
- 12.13.2 BioVigil Healthcare Systems Business Overview
- 12.13.3 BioVigil Healthcare Systems Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.13.4 BioVigil Healthcare Systems AI-Based Infection Control System Product Portfolio
- 12.13.5 BioVigil Healthcare Systems Recent Developments
- 12.14 SwipeSense
- 12.14.1 SwipeSense Company Information
- 12.14.2 SwipeSense Business Overview
- 12.14.3 SwipeSense Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.14.4 SwipeSense AI-Based Infection Control System Product Portfolio
- 12.14.5 SwipeSense Recent Developments
- 12.15 GOJO Industries
- 12.15.1 GOJO Industries Company Information
- 12.15.2 GOJO Industries Business Overview
- 12.15.3 GOJO Industries Revenue in AI-Based Infection Control System Business (2021-2026)
- 12.15.4 GOJO Industries AI-Based Infection Control System Product Portfolio
- 12.15.5 GOJO Industries Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst